Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2005-06-24
Summary
OBJECTIVES:
I. Determine specific clinical features, molecular abnormalities, and laboratory-based biological markers of free radical stress that are associated with amyotrophic lateral sclerosis and influence disease severity.
Conditions
Sponsors & Collaborators
-
Massachusetts General Hospital
collaborator OTHER -
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Merit E. Cudkowicz · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-03-31
More Related Trials
-
Neuromuscular Magnetic Stimulation in ALS Patients
NCT03618966 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713 ·Status: TERMINATED ·Phase: NA
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
NCT05423678 ·Status: NOT_YET_RECRUITING
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
NCT00023075 ·Status: COMPLETED
-
Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments
NCT04816227 ·Status: RECRUITING
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
Analysis of Human ALS Tissues and Registry of ALS Patients
NCT05067179 ·Status: RECRUITING
-
Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis
NCT02874209 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
NCT02794857 ·Status: COMPLETED ·Phase: PHASE2
-
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
NCT05663008 ·Status: RECRUITING
-
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
NCT06351735 ·Status: NOT_YET_RECRUITING
-
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Performance of a Diagnostic Test in ALS
NCT02759913 ·Status: UNKNOWN
-
Muscular Biomarkers in Amyotrophic Lateral Sclerosis
NCT02670226 ·Status: COMPLETED ·Phase: NA
-
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
NCT04394871 ·Status: RECRUITING
-
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis
NCT04455542 ·Status: COMPLETED
-
New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis
NCT04691011 ·Status: COMPLETED ·Phase: NA
-
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845 ·Status: ENROLLING_BY_INVITATION
-
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
NCT00718458 ·Status: COMPLETED
-
Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
NCT07007390 ·Status: NOT_YET_RECRUITING
-
Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
NCT02242071 ·Status: WITHDRAWN ·Phase: PHASE1
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING